Bay Street News, April 29th, 2020

REDWOOD CITY, Calif., April 29, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on […]

On track to initiate the OPTION 2 trial by the end of Q2 2020OPTION 2 trial to compare efficacy of […]

DUNMORE, Pa., April 29, 2020 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary […]

FARMERS BRANCH, Texas, April 29, 2020 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) announced today that it will […]

CAMBRIDGE, Mass., April 29, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering […]

PORTLAND, Maine, April 29, 2020 (GLOBE NEWSWIRE) — Consolidated Communications, Holdings, Inc., (NASDAQ: CNSL), a leading broadband and business communications […]

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a New York-based global […]

SOUTH SAN FRANCISCO, Calif., April 29, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that […]

PHILADELPHIA, April 29, 2020 (GLOBE NEWSWIRE) — Republic First Bancorp, Inc. (NASDAQ: FRBK), the holding company for Republic Bank, today […]

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of and […]